Category Archives: Up and Down

$SGPY…where is the Synergy?

First: Happy Birthday to Home Sweet Home, the US of A! I thought it would be fun to take a look at Synergy Pharmaceuticals ($SGYP) to see how they could represent the intent of its namesake.  By definition, synergy is … Continue reading

Posted in Up and Down | Tagged , , , , , , , , , , | Leave a comment

Expect the unexpected

In biotech, always expect the unexpected. Over the past 9-mo, Savient Pharmaceuticals ($SVNT) has seen its market cap explode to $1.6B with Krystexxa (pegloticase) approval for treatment refractory gout, only to see its value fall past its pre-approval valuation of … Continue reading

Posted in Up and Down | Tagged , , , | Leave a comment